FRESENIUS MEDICAL CARE AG (FME.DE) Fundamental Analysis & Valuation

FRA:FME • DE0005785802

Current stock price

38.54 EUR
-0.4 (-1.03%)
Last:

This FME.DE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

6

1. FME.DE Profitability Analysis

1.1 Basic Checks

  • In the past year FME was profitable.
  • In the past year FME had a positive cash flow from operations.
  • In the past 5 years FME has always been profitable.
  • Each year in the past 5 years FME had a positive operating cash flow.
FME.DE Yearly Net Income VS EBIT VS OCF VS FCFFME.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B

1.2 Ratios

  • With a decent Return On Assets value of 3.16%, FME is doing good in the industry, outperforming 66.67% of the companies in the same industry.
  • FME has a Return On Equity of 7.35%. This is comparable to the rest of the industry: FME outperforms 55.56% of its industry peers.
  • FME's Return On Invested Capital of 5.30% is in line compared to the rest of the industry. FME outperforms 55.56% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for FME is in line with the industry average of 5.99%.
  • The 3 year average ROIC (4.02%) for FME is below the current ROIC(5.30%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 3.16%
ROE 7.35%
ROIC 5.3%
ROA(3y)2.08%
ROA(5y)2.19%
ROE(3y)4.9%
ROE(5y)5.43%
ROIC(3y)4.02%
ROIC(5y)3.98%
FME.DE Yearly ROA, ROE, ROICFME.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15

1.3 Margins

  • The Profit Margin of FME (4.98%) is better than 85.19% of its industry peers.
  • In the last couple of years the Profit Margin of FME has declined.
  • FME has a better Operating Margin (9.00%) than 77.78% of its industry peers.
  • FME's Operating Margin has declined in the last couple of years.
  • FME has a Gross Margin (25.62%) which is comparable to the rest of the industry.
  • FME's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 9%
PM (TTM) 4.98%
GM 25.62%
OM growth 3Y10.69%
OM growth 5Y-6.44%
PM growth 3Y12.82%
PM growth 5Y-5.23%
GM growth 3Y0.52%
GM growth 5Y-3.74%
FME.DE Yearly Profit, Operating, Gross MarginsFME.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. FME.DE Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), FME is destroying value.
  • The number of shares outstanding for FME has been reduced compared to 1 year ago.
  • FME has less shares outstanding than it did 5 years ago.
  • Compared to 1 year ago, FME has a worse debt to assets ratio.
FME.DE Yearly Shares OutstandingFME.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M
FME.DE Yearly Total Debt VS Total AssetsFME.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10B 20B 30B

2.2 Solvency

  • FME has an Altman-Z score of 2.17. This is not the best score and indicates that FME is in the grey zone with still only limited risk for bankruptcy at the moment.
  • FME has a Altman-Z score of 2.17. This is in the better half of the industry: FME outperforms 70.37% of its industry peers.
  • FME has a debt to FCF ratio of 6.19. This is a slightly negative value and a sign of low solvency as FME would need 6.19 years to pay back of all of its debts.
  • FME's Debt to FCF ratio of 6.19 is fine compared to the rest of the industry. FME outperforms 77.78% of its industry peers.
  • A Debt/Equity ratio of 0.65 indicates that FME is somewhat dependend on debt financing.
  • With an excellent Debt to Equity ratio value of 0.65, FME belongs to the best of the industry, outperforming 81.48% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.65
Debt/FCF 6.19
Altman-Z 2.17
ROIC/WACC0.92
WACC5.77%
FME.DE Yearly LT Debt VS Equity VS FCFFME.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B

2.3 Liquidity

  • FME has a Current Ratio of 1.26. This is a normal value and indicates that FME is financially healthy and should not expect problems in meeting its short term obligations.
  • With a decent Current ratio value of 1.26, FME is doing good in the industry, outperforming 70.37% of the companies in the same industry.
  • FME has a Quick Ratio of 1.26. This is a bad value and indicates that FME is not financially healthy enough and could expect problems in meeting its short term obligations.
  • FME has a Quick ratio of 0.92. This is in the better half of the industry: FME outperforms 62.96% of its industry peers.
Industry RankSector Rank
Current Ratio 1.26
Quick Ratio 0.92
FME.DE Yearly Current Assets VS Current LiabilitesFME.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. FME.DE Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 32.00% over the past year.
  • The Earnings Per Share has been decreasing by -1.51% on average over the past years.
  • Looking at the last year, FME shows a small growth in Revenue. The Revenue has grown by 1.51% in the last year.
  • FME shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 1.91% yearly.
EPS 1Y (TTM)32%
EPS 3Y11.44%
EPS 5Y-1.51%
EPS Q2Q%58.24%
Revenue 1Y (TTM)1.51%
Revenue growth 3Y0.39%
Revenue growth 5Y1.91%
Sales Q2Q%-0.29%

3.2 Future

  • Based on estimates for the next years, FME will show a quite strong growth in Earnings Per Share. The EPS will grow by 9.03% on average per year.
  • Based on estimates for the next years, FME will show a small growth in Revenue. The Revenue will grow by 3.69% on average per year.
EPS Next Y-6.53%
EPS Next 2Y2.07%
EPS Next 3Y6.69%
EPS Next 5Y9.03%
Revenue Next Year0.74%
Revenue Next 2Y2.42%
Revenue Next 3Y2.64%
Revenue Next 5Y3.69%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
FME.DE Yearly Revenue VS EstimatesFME.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 5B 10B 15B 20B 25B
FME.DE Yearly EPS VS EstimatesFME.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 2 4 6

More info and screens

Find the best growth stocksShow best growing peers

6

4. FME.DE Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 8.98, which indicates a very decent valuation of FME.
  • 96.30% of the companies in the same industry are more expensive than FME, based on the Price/Earnings ratio.
  • Compared to an average S&P500 Price/Earnings ratio of 24.89, FME is valued rather cheaply.
  • FME is valuated reasonably with a Price/Forward Earnings ratio of 9.61.
  • Based on the Price/Forward Earnings ratio, FME is valued cheaper than 85.19% of the companies in the same industry.
  • FME is valuated cheaply when we compare the Price/Forward Earnings ratio to 22.19, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 8.98
Fwd PE 9.61
FME.DE Price Earnings VS Forward Price EarningsFME.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20

4.2 Price Multiples

  • The rest of the industry has a similar Enterprise Value to EBITDA ratio as FME.
  • FME's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 12.35
EV/EBITDA 9.13
FME.DE Per share dataFME.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30

4.3 Compensation for Growth

  • FME has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y2.07%
EPS Next 3Y6.69%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

7

5. FME.DE Dividend Analysis

5.1 Amount

  • FME has a Yearly Dividend Yield of 3.70%.
  • FME's Dividend Yield is rather good when compared to the industry average which is at 1.77. FME pays more dividend than 96.30% of the companies in the same industry.
  • Compared to an average S&P500 Dividend Yield of 1.89, FME pays a better dividend.
Industry RankSector Rank
Dividend Yield 3.7%

5.2 History

  • The dividend of FME has a limited annual growth rate of 4.43%.
Dividend Growth(5Y)4.43%
Div Incr Years1
Div Non Decr Years2
FME.DE Yearly Dividends per shareFME.DE Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 2026 0.5 1 1.5 2

5.3 Sustainability

  • FME pays out 43.19% of its income as dividend. This is a bit on the high side, but may be sustainable.
  • FME's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP43.19%
EPS Next 2Y2.07%
EPS Next 3Y6.69%
FME.DE Yearly Income VS Free CF VS DividendFME.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B
FME.DE Dividend Payout.FME.DE Dividend Payout, showing the Payout Ratio.FME.DE Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

FME.DE Fundamentals: All Metrics, Ratios and Statistics

FRESENIUS MEDICAL CARE AG

FRA:FME (3/27/2026, 7:00:00 PM)

38.54

-0.4 (-1.03%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)02-24
Earnings (Next)05-05
Inst Owners44.27%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap21.53B
Revenue(TTM)19.63B
Net Income(TTM)978.37M
Analysts65.93
Price Target45.41 (17.83%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 3.7%
Yearly Dividend1.48
Dividend Growth(5Y)4.43%
DP43.19%
Div Incr Years1
Div Non Decr Years2
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)24.86%
Min EPS beat(2)14.16%
Max EPS beat(2)35.55%
EPS beat(4)4
Avg EPS beat(4)22.94%
Min EPS beat(4)14.16%
Max EPS beat(4)35.55%
EPS beat(8)8
Avg EPS beat(8)21.57%
EPS beat(12)10
Avg EPS beat(12)16.05%
EPS beat(16)12
Avg EPS beat(16)12.94%
Revenue beat(2)1
Avg Revenue beat(2)0.93%
Min Revenue beat(2)-1.71%
Max Revenue beat(2)3.58%
Revenue beat(4)2
Avg Revenue beat(4)0.32%
Min Revenue beat(4)-3.33%
Max Revenue beat(4)3.58%
Revenue beat(8)4
Avg Revenue beat(8)-0.14%
Revenue beat(12)5
Avg Revenue beat(12)-0.25%
Revenue beat(16)7
Avg Revenue beat(16)-0.28%
PT rev (1m)-0.82%
PT rev (3m)-4.61%
EPS NQ rev (1m)21.82%
EPS NQ rev (3m)29.57%
EPS NY rev (1m)-3.3%
EPS NY rev (3m)-3.3%
Revenue NQ rev (1m)-2.64%
Revenue NQ rev (3m)-5.93%
Revenue NY rev (1m)-1.34%
Revenue NY rev (3m)-2.09%
Valuation
Industry RankSector Rank
PE 8.98
Fwd PE 9.61
P/S 1.1
P/FCF 12.35
P/OCF 8.03
P/B 1.62
P/tB N/A
EV/EBITDA 9.13
EPS(TTM)4.29
EY11.13%
EPS(NY)4.01
Fwd EY10.4%
FCF(TTM)3.12
FCFY8.1%
OCF(TTM)4.8
OCFY12.45%
SpS35.14
BVpS23.83
TBVpS-2.71
PEG (NY)N/A
PEG (5Y)N/A
Graham Number47.96
Profitability
Industry RankSector Rank
ROA 3.16%
ROE 7.35%
ROCE 7.13%
ROIC 5.3%
ROICexc 5.78%
ROICexgc 16.63%
OM 9%
PM (TTM) 4.98%
GM 25.62%
FCFM 8.88%
ROA(3y)2.08%
ROA(5y)2.19%
ROE(3y)4.9%
ROE(5y)5.43%
ROIC(3y)4.02%
ROIC(5y)3.98%
ROICexc(3y)4.29%
ROICexc(5y)4.23%
ROICexgc(3y)11.55%
ROICexgc(5y)11.07%
ROCE(3y)5.42%
ROCE(5y)5.44%
ROICexgc growth 3Y23.76%
ROICexgc growth 5Y-0.49%
ROICexc growth 3Y19.48%
ROICexc growth 5Y-3.49%
OM growth 3Y10.69%
OM growth 5Y-6.44%
PM growth 3Y12.82%
PM growth 5Y-5.23%
GM growth 3Y0.52%
GM growth 5Y-3.74%
F-Score8
Asset Turnover0.63
Health
Industry RankSector Rank
Debt/Equity 0.65
Debt/FCF 6.19
Debt/EBITDA 2.64
Cap/Depr 62.47%
Cap/Sales 4.78%
Interest Coverage 4.9
Cash Conversion 82.09%
Profit Quality 178.22%
Current Ratio 1.26
Quick Ratio 0.92
Altman-Z 2.17
F-Score8
WACC5.77%
ROIC/WACC0.92
Cap/Depr(3y)48.17%
Cap/Depr(5y)48.21%
Cap/Sales(3y)4.06%
Cap/Sales(5y)4.23%
Profit Quality(3y)290.62%
Profit Quality(5y)248.93%
High Growth Momentum
Growth
EPS 1Y (TTM)32%
EPS 3Y11.44%
EPS 5Y-1.51%
EPS Q2Q%58.24%
EPS Next Y-6.53%
EPS Next 2Y2.07%
EPS Next 3Y6.69%
EPS Next 5Y9.03%
Revenue 1Y (TTM)1.51%
Revenue growth 3Y0.39%
Revenue growth 5Y1.91%
Sales Q2Q%-0.29%
Revenue Next Year0.74%
Revenue Next 2Y2.42%
Revenue Next 3Y2.64%
Revenue Next 5Y3.69%
EBIT growth 1Y39.46%
EBIT growth 3Y11.12%
EBIT growth 5Y-4.66%
EBIT Next Year71.81%
EBIT Next 3Y24.11%
EBIT Next 5Y15.26%
FCF growth 1Y4.8%
FCF growth 3Y7.67%
FCF growth 5Y-11.14%
OCF growth 1Y12.36%
OCF growth 3Y7.35%
OCF growth 5Y-8.73%

FRESENIUS MEDICAL CARE AG / FME.DE Fundamental Analysis FAQ

What is the fundamental rating for FME stock?

ChartMill assigns a fundamental rating of 6 / 10 to FME.DE.


What is the valuation status for FME stock?

ChartMill assigns a valuation rating of 6 / 10 to FRESENIUS MEDICAL CARE AG (FME.DE). This can be considered as Fairly Valued.


Can you provide the profitability details for FRESENIUS MEDICAL CARE AG?

FRESENIUS MEDICAL CARE AG (FME.DE) has a profitability rating of 6 / 10.


What is the valuation of FRESENIUS MEDICAL CARE AG based on its PE and PB ratios?

The Price/Earnings (PE) ratio for FRESENIUS MEDICAL CARE AG (FME.DE) is 8.98 and the Price/Book (PB) ratio is 1.62.


How sustainable is the dividend of FRESENIUS MEDICAL CARE AG (FME.DE) stock?

The dividend rating of FRESENIUS MEDICAL CARE AG (FME.DE) is 7 / 10 and the dividend payout ratio is 43.19%.